cro.directory
← Compare landing

Icosagen vs Solvias

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/icosagen/solvias

CategoryIcosagenSolvias
Listed sitebothcro
SummaryIcosagen is an integrated CRDMO (Contract Research, Development & Manufacturing Organization) specializing in antibody discovery, protein production, cell line development, and GMP manufacturing for biologics programs from discovery through commercial scale.Global cGMP contract research organization providing comprehensive analytical services for drug development, from preclinical through commercialization, with expertise in biologics, cell & gene therapies, and small molecules.
Services
  • Cell-Line Development
  • Recombinant Protein Manufacturing
  • Process Development
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Bioconjugation Services
  • Biologics Development & Manufacturing
  • CMC Analytical Development
  • Analytical Method Development & Validation
  • Stability Testing & Storage
  • ICH Stability Studies
  • Extractables & Leachables Studies
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Cell-Line Development
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Estonia
  • Headquarters, Kaiseraugst, Basel-Landschaft, Switzerland
  • Center of Excellence for Biologics and Cell & Gene Therapy, Research Triangle Park, North Carolina, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.